C

Corcept Therapeutics
D

CORT

57.500
USD
1.58
(2.83%)
Market Closed
Volume
19,692
EPS
1
Div Yield
-
P/E
46
Market Cap
6,024,570,378
OverviewSignalsIdeasNews
Related Instruments
    ALNY
    ALNY
    -22.650
    (-8.77%)
    235.480 USD
    C
    CRBP
    -0.950
    (-5.41%)
    16.610 USD
    C
    CRIS
    -0.04000
    (-1.00%)
    3.96000 USD
    G
    GLPG
    -1.130
    (-4.05%)
    26.780 USD
    I
    INSM
    -4.950
    (-6.95%)
    66.310 USD
    X
    XLRN
    0
    (0%)
    0.000000 USD
    More
News

Title: Corcept Therapeutics

Sector: Healthcare
Industry: Biotechnology
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.